Use of a pharmaceutical composition for the treatment of pathologies derived from infection by herpes virus, papillomavirus, hepatitis virus, viral neuralgia, viral dsyplasia, immune-deficiency-induced viral infections and viral neuritis.

摘要

Use of a pharmaceutical composition including: 10-40% magnesium oxide, 10-40% DL-methionine, 0.1-5% calcium glycerophosphate, 0.1-3% ferric glycerophosphate, and 0.1-3% manganese glycerophosphate, for treating one of a group of pathologies including pathologies derived from infection by herpesvirus, pathologies derived from infection by papilloma virus, pathologies derived from infection by hepatitis virus, viral neuralgia, viral dysplasia, immune-deficiency-induced viral infections, and viral neuritis.